Your browser doesn't support javascript.
loading
Vaccine adjuvants as potential cancer immunotherapeutics.
Temizoz, Burcu; Kuroda, Etsushi; Ishii, Ken J.
  • Temizoz B; Laboratory of Vaccine Science, WPI Immunology Frontier Research Center (iFReC), Osaka University, 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan Laboratory of Adjuvant Innovation, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Asagi, Saito, Ibaraki-City, Osaka 567-0085, Japan.
  • Kuroda E; Laboratory of Vaccine Science, WPI Immunology Frontier Research Center (iFReC), Osaka University, 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan Laboratory of Adjuvant Innovation, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Asagi, Saito, Ibaraki-City, Osaka 567-0085, Japan.
  • Ishii KJ; Laboratory of Vaccine Science, WPI Immunology Frontier Research Center (iFReC), Osaka University, 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan Laboratory of Adjuvant Innovation, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Asagi, Saito, Ibaraki-City, Osaka 567-0085, Japan kenishii@biken.osaka-u.ac.jp.
Int Immunol ; 28(7): 329-38, 2016 07.
Article en En | MEDLINE | ID: mdl-27006304

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oligodesoxirribonucleótidos / Adyuvantes Inmunológicos / Vacunas contra el Cáncer / Lectinas Tipo C / Compuestos de Alumbre / Inmunoterapia / Neoplasias Límite: Animals / Humans Idioma: En Año: 2016 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oligodesoxirribonucleótidos / Adyuvantes Inmunológicos / Vacunas contra el Cáncer / Lectinas Tipo C / Compuestos de Alumbre / Inmunoterapia / Neoplasias Límite: Animals / Humans Idioma: En Año: 2016 Tipo del documento: Article